Advertisement
News & Literature Highlights
Case Studies
ICANS or TIAN? Neurologic Toxicity Following CAR T-Cell Therapy in a Patient With Primary Central Nervous System Lymphoma
Identifying and Managing CAR T-Associated Hemophagocytic Lymphohistiocytosis Following Dual-Targeted CAR T-Cell Therapy
Prophylactic Tocilizumab in Selected High-Risk or Outpatient CAR-T Populations
Quizzes
Test your knowledge of neurologic toxicity following CAR T-cell therapy in patients with primary central nervous system lymphoma
Test your knowledge of CAR T-associated HLH following dual-targeted CAR T-cell therapy
Test your knowledge of prophylactic strategies in selected high-risk or outpatient CAR-T populations